<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>10</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2021</Year>
					<Month>02</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Potential for Early Health Economic Modelling in Health Technology Assessment and Reimbursement Decision-Making; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>98</FirstPage>
			<LastPage>101</LastPage>
			<ELocationID EIdType="pii">3753</ELocationID>
			
<ELocationID EIdType="doi">10.15171/ijhpm.2020.17</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Hansoo</FirstName>
					<LastName>Kim</LastName>
<Affiliation>School of Public Health and Preventive Medicine, Monash University, Melbourne,
VIC, Australia</Affiliation>

</Author>
<Author>
					<FirstName>Stephen</FirstName>
					<LastName>Goodall</LastName>
<Affiliation>Centre for Health Economics Research and Evaluation, University
of Technology Sydney, Ultimo, NSW, Australia</Affiliation>

</Author>
<Author>
					<FirstName>Danny</FirstName>
					<LastName>Liew</LastName>
<Affiliation>School of Public Health and Preventive Medicine, Monash University, Melbourne,
VIC, Australia</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>10</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;Grutters et al recently investigated the role of early health economic modelling of health technologies by undertaking a secondary analysis of health economic modelling assessments performed by their group. Our commentary offers a broad perspective on the potential utility of early health economic modelling to inform health technology assessment (HTA) and decision-making around reimbursement of new health technologies. Further we provide several examples to compliment Grutters and colleagues’ observations.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Early Assessment</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Health Economic Modelling</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Reimbursement</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Health Technology Assessment</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Australia</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3753_8da4b9b34ddea7c70f241f380ec6fb4e.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
